SOUTH SAN FRANCISCO, Calif., & PARIS--(BUSINESS WIRE)--DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) and DNA on demand, has been named to Fast Company’s prestigious annual list of the ...
Founding CEO Thomas Ybert transitions to Chief Scientific Officer role to underscore company’s ongoing commitment to scientific discovery and innovation PARIS & DALY CITY, Calif.--(BUSINESS WIRE)--DNA ...
DNA Script has signed distribution agreements with Gencell, Bio-Medical Science (BMS) and Biostream, expanding global access ...
DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced it has signed distribution agreements with Gencell, Bio-Medical Science Co ...
The positions in the table below reflect the DNA Script SAS's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...
DNA Script SAS is closing a $200 million series C fundraising round, with new investors pumping in cash to push commercialization of its DNA printing platform Syntax. The company has raised a total of ...
Enables researchers worldwide to access high-quality ssDNA oligonucleotides within hours Establishes direct distribution networks across Latin America, Japan and South Korea This expansion supports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results